RecruitingPhase 2NCT05100095

Hypofractionated Radiation Therapy for Merkel Cell Carcinoma


Sponsor

M.D. Anderson Cancer Center

Enrollment

52 participants

Start Date

Dec 14, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This phase II trial tests whether hypofractionated radiation works to treat patients with Merkel cell carcinoma. Radiation therapy uses high energy radio waves to kill cancer cells and shrink tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may be more convenient for patients and less immunosuppressive.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a shorter, more intense course of radiation therapy (called hypofractionation) is as safe and effective as the standard radiation approach for people with Merkel cell carcinoma, a rare and aggressive type of skin cancer. **You may be eligible if...** - You have been diagnosed with Merkel cell carcinoma, confirmed by biopsy - You have no evidence of cancer spreading to distant parts of the body - You have had surgery to remove the primary tumor within the last 4 months, OR - You have had lymph node surgery within the last 4 months and have specific high-risk features - Receiving immunotherapy alongside radiation is permitted **You may NOT be eligible if...** - Your cancer has spread to distant organs - You are not a candidate for radiation therapy - You have had prior radiation to the same area Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRadiation therapy

Hypofractionated radiation therapy to the primary tumor and/or lymph nodes


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05100095


Related Trials